The FDA has granted approval to subcutaneous Keytruda for use in adults and pediatric patients with a solid tumor.

Subcutaneous pembrolizumab has been approved across all indications, cutting chair and administration times with a median ...

The U.S. Food and Drug Administration said on Friday it has approved a new formulation of Merck's blockbuster cancer therapy ...

Merck said Friday the injection, called Keytruda Qlex, has shown comparable effectiveness to the IV form of the drug. The company said it would provide greater convenience as it can be offered in a ...

The first immune checkpoint inhibitor that can be administered via a subcutaneous injection in just 1 to 2 minutes has ...

The agency approved the injectable version in all settings for which the intravenous version is approved, including biomarker-defined indications.

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat ...

The U.S. Food and Drug Administration said on Friday it had approved Stealth Biotherapeutics' once-daily injection for a rare, genetic disease that primarily affects males, making it the first ...